Literature DB >> 19018527

Radiobiological considerations for radioembolization with 188Re-microspheres.

Liane Oehme, Jörg Kotzerke.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19018527     DOI： 10.1007/s00259-008-0991-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  16 in total

1.  Application of the linear-quadratic model with incomplete repair to radionuclide directed therapy.

Authors:  W T Millar
Journal:  Br J Radiol       Date:  1991-03       Impact factor: 3.039

2.  A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine.

Authors:  Gerd Wunderlich; Antje Drews; Jörg Kotzerke
Journal:  Appl Radiat Isot       Date:  2005-06       Impact factor: 1.513

3.  [Influence of time-dose-relationships in therapeutic nuclear medicine applications on biological effectiveness of irradiation: consequences for dosimetry].

Authors:  L Oehme; W Dörr; P Wust; J Kotzerke
Journal:  Nuklearmedizin       Date:  2008       Impact factor: 1.379

Review 4.  Dose-rate effects in targeted radiotherapy.

Authors:  R G Dale
Journal:  Phys Med Biol       Date:  1996-10       Impact factor: 3.609

5.  Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.

Authors:  Raffaella Barone; Françoise Borson-Chazot; Roelf Valkema; Stéphan Walrand; Franck Chauvin; Lida Gogou; Larry K Kvols; Eric P Krenning; François Jamar; Stanislas Pauwels
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

6.  (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.

Authors:  Bieke Lambert; Klaus Bacher; Luc Defreyne; Hans Van Vlierberghe; Jae Min Jeong; Rong Fu Wang; Jan van Meerbeeck; Peter Smeets; Roberto Troisi; Hubert Thierens; Filip De Vos; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12-07       Impact factor: 9.236

7.  Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Authors:  Laura M Kulik; Brian I Carr; Mary F Mulcahy; Robert J Lewandowski; Bassel Atassi; Robert K Ryu; Kent T Sato; Al Benson; Albert A Nemcek; Vanessa L Gates; Michael Abecassis; Reed A Omary; Riad Salem
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

8.  Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry.

Authors:  Sébastien Baechler; Robert F Hobbs; Andrew R Prideaux; Richard L Wahl; George Sgouros
Journal:  Med Phys       Date:  2008-03       Impact factor: 4.071

9.  Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment.

Authors:  Marta Cremonesi; Mahila Ferrari; Mirco Bartolomei; Franco Orsi; Guido Bonomo; Demetrio Aricò; Andrew Mallia; Concetta De Cicco; Guido Pedroli; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-10       Impact factor: 9.236

10.  Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.

Authors:  Patricia Bernal; Jean-Luc Raoul; Gaj Vidmar; Erdenechimeg Sereegotov; Felix X Sundram; Ajay Kumar; Jae Min Jeong; Pawana Pusuwan; Chaitanya Divgi; Pat Zanzonico; Janez Stare; John Buscombe; Chau Trinh Thi Minh; Maung Maung Saw; Shaoliang Chen; Ruben Ogbac; Ajit K Padhy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-09       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.